Press-release for stocks publishing date 2021 - 11

Prices are updated after-hours

| -4.19% | O: 0.74% H: 0.0% C: 0.0%
treatment cancer negative breast cancer

Gilead and AWS Collaborate on Development and Delivery of New Medicines for Patients
Published: 2021-11-29 (Crawled : 15:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M

| -4.19% | O: 0.74% H: 0.0% C: 0.0%
AMZN S | $176.57 -1.65% -3.18% 32M

| -94.96% | O: 1.2% H: 0.0% C: 0.0%
liver collaboration

| -4.19% | O: 0.74% H: 0.0% C: 0.0%
GTHX | $3.98 -5.01% -5.28% 340K

| -69.95% | O: 0.75% H: 0.82% C: -6.28%
phase 2 trilaciclib antibody drug trial therapeutics

| -4.19% | O: 0.74% H: 0.0% C: 0.0%
GTHX | $3.98 -5.01% -5.28% 340K

| -69.95% | O: 0.75% H: 0.82% C: -6.28%
trodelvy phase 2 trilaciclib antibody drug trial therapeutics

62%

38%

CSSE 4 | $0.4323 183.85% 64.77% 220M

BOF | $1.99 70.09% 41.21% 110M

ILAG | $0.51 6.03% 40.62% 1.7M

LICN | $0.941 68.04% 40.49% 15M

AMST | $3.31 65.5% 39.58% 70M

MTC | $3.615 61.38% 38.04% 9.3M

WIMI | $1.15 58.53% 36.92% 19M

AIH | $0.45 12.5% 30.92% 320K

MULN | News | $3.78 38.46% 27.78% 13M

RILY | $29.86 37.48% 27.26% 12M

Save your searches and get alerts when important news are released.